-DOCSTART- -X- O
INTRODUCTION -X- _ O
: -X- _ O
Most -X- _ O
cases -X- _ O
of -X- _ O
the -X- _ O
2009 -X- _ B-Patient
influenza -X- _ I-Patient
A -X- _ I-Patient
( -X- _ I-Patient
H1N1 -X- _ I-Patient
) -X- _ I-Patient
infection -X- _ I-Patient
are -X- _ O
self-limited -X- _ O
, -X- _ O
but -X- _ O
occasionally -X- _ O
the -X- _ O
disease -X- _ O
evolves -X- _ O
to -X- _ O
a -X- _ O
severe -X- _ O
condition -X- _ O
needing -X- _ O
hospitalization. -X- _ O
Here -X- _ O
we -X- _ O
describe -X- _ O
the -X- _ O
evolution -X- _ O
of -X- _ O
the -X- _ O
respiratory -X- _ O
compromise -X- _ O
, -X- _ O
ventilatory -X- _ O
management -X- _ O
and -X- _ O
laboratory -X- _ O
variables -X- _ O
of -X- _ O
patients -X- _ O
with -X- _ O
diffuse -X- _ O
viral -X- _ O
pneumonitis -X- _ O
caused -X- _ O
by -X- _ O
pandemic -X- _ O
2009 -X- _ O
influenza -X- _ O
A -X- _ O
( -X- _ O
H1N1 -X- _ O
) -X- _ O
admitted -X- _ O
to -X- _ O
the -X- _ O
ICU. -X- _ O
METHOD -X- _ O
: -X- _ O
This -X- _ O
was -X- _ O
a -X- _ O
multicenter -X- _ O
, -X- _ O
prospective -X- _ O
inception -X- _ O
cohort -X- _ O
study -X- _ O
including -X- _ O
adult -X- _ B-Patient
patients -X- _ I-Patient
with -X- _ I-Patient
acute -X- _ I-Patient
respiratory -X- _ I-Patient
failure -X- _ I-Patient
requiring -X- _ O
mechanical -X- _ B-Intervention
ventilation -X- _ I-Intervention
( -X- _ I-Intervention
MV -X- _ I-Intervention
) -X- _ I-Intervention
admitted -X- _ O
to -X- _ O
20 -X- _ O
ICUs -X- _ O
in -X- _ O
Argentina -X- _ O
between -X- _ O
June -X- _ O
and -X- _ O
September -X- _ O
of -X- _ O
2009 -X- _ O
during -X- _ O
the -X- _ O
influenza -X- _ O
A -X- _ O
( -X- _ O
H1N1 -X- _ O
) -X- _ O
pandemic. -X- _ O
In -X- _ O
a -X- _ O
standard -X- _ O
case-report -X- _ O
form -X- _ O
, -X- _ O
we -X- _ O
collected -X- _ O
epidemiological -X- _ O
characteristics -X- _ O
, -X- _ O
results -X- _ O
of -X- _ O
real-time -X- _ O
reverse-transcriptase -X- _ O
-- -X- _ O
polymerase-chain-reaction -X- _ O
viral -X- _ O
diagnostic -X- _ O
tests -X- _ O
, -X- _ O
oxygenation -X- _ O
variables -X- _ O
, -X- _ O
acid-base -X- _ O
status -X- _ O
, -X- _ O
respiratory -X- _ O
mechanics -X- _ O
, -X- _ O
ventilation -X- _ O
management -X- _ O
and -X- _ O
laboratory -X- _ O
tests. -X- _ O
Variables -X- _ O
were -X- _ O
recorded -X- _ O
on -X- _ O
ICU -X- _ O
admission -X- _ O
and -X- _ O
at -X- _ O
days -X- _ O
3 -X- _ O
, -X- _ O
7 -X- _ O
and -X- _ O
10. -X- _ O
RESULTS -X- _ O
: -X- _ O
During -X- _ O
the -X- _ O
study -X- _ O
period -X- _ O
178 -X- _ B-Patient
patients -X- _ I-Patient
with -X- _ I-Patient
diffuse -X- _ I-Patient
viral -X- _ I-Patient
pneumonitis -X- _ I-Patient
requiring -X- _ O
MV -X- _ O
were -X- _ O
admitted. -X- _ O
They -X- _ O
were -X- _ O
44 -X- _ B-Patient
± -X- _ I-Patient
15 -X- _ I-Patient
years -X- _ I-Patient
of -X- _ I-Patient
age -X- _ I-Patient
, -X- _ I-Patient
with -X- _ I-Patient
Acute -X- _ I-Patient
Physiology -X- _ I-Patient
And -X- _ I-Patient
Chronic -X- _ I-Patient
Health -X- _ I-Patient
Evaluation -X- _ I-Patient
II -X- _ I-Patient
( -X- _ I-Patient
APACHE -X- _ I-Patient
II -X- _ I-Patient
) -X- _ I-Patient
scores -X- _ I-Patient
of -X- _ I-Patient
18 -X- _ I-Patient
± -X- _ I-Patient
7 -X- _ I-Patient
, -X- _ I-Patient
and -X- _ I-Patient
most -X- _ I-Patient
frequent -X- _ I-Patient
comorbidities -X- _ I-Patient
were -X- _ I-Patient
obesity -X- _ I-Patient
( -X- _ I-Patient
26 -X- _ I-Patient
% -X- _ I-Patient
) -X- _ I-Patient
, -X- _ I-Patient
previous -X- _ I-Patient
respiratory -X- _ I-Patient
disease -X- _ I-Patient
( -X- _ I-Patient
24 -X- _ I-Patient
% -X- _ I-Patient
) -X- _ I-Patient
and -X- _ I-Patient
immunosuppression -X- _ I-Patient
( -X- _ I-Patient
16 -X- _ I-Patient
% -X- _ I-Patient
) -X- _ I-Patient
. -X- _ O
Non-invasive -X- _ B-Outcome
ventilation -X- _ I-Outcome
( -X- _ I-Outcome
NIV -X- _ I-Outcome
) -X- _ I-Outcome
was -X- _ I-Outcome
applied -X- _ I-Outcome
in -X- _ I-Outcome
49 -X- _ I-Outcome
( -X- _ I-Outcome
28 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
patients -X- _ I-Outcome
on -X- _ I-Outcome
admission -X- _ I-Outcome
, -X- _ I-Outcome
but -X- _ I-Outcome
94 -X- _ I-Outcome
% -X- _ I-Outcome
were -X- _ I-Outcome
later -X- _ I-Outcome
intubated. -X- _ I-Outcome
Acute -X- _ I-Outcome
respiratory -X- _ I-Outcome
distress -X- _ I-Outcome
syndrome -X- _ I-Outcome
( -X- _ I-Outcome
ARDS -X- _ I-Outcome
) -X- _ I-Outcome
was -X- _ I-Outcome
present -X- _ I-Outcome
throughout -X- _ I-Outcome
the -X- _ I-Outcome
entire -X- _ I-Outcome
ICU -X- _ I-Outcome
stay -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
whole -X- _ I-Outcome
group -X- _ I-Outcome
( -X- _ I-Outcome
mean -X- _ I-Outcome
PaO -X- _ I-Outcome
( -X- _ I-Outcome
2 -X- _ I-Outcome
) -X- _ I-Outcome
/ -X- _ I-Outcome
FIO -X- _ I-Outcome
( -X- _ I-Outcome
2 -X- _ I-Outcome
) -X- _ I-Outcome
170 -X- _ I-Outcome
± -X- _ I-Outcome
25 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
Tidal- -X- _ I-Outcome
volumes -X- _ I-Outcome
used -X- _ I-Outcome
were -X- _ I-Outcome
7.8 -X- _ I-Outcome
to -X- _ I-Outcome
8.1 -X- _ I-Outcome
ml -X- _ I-Outcome
/ -X- _ I-Outcome
kg -X- _ I-Outcome
( -X- _ I-Outcome
ideal -X- _ I-Outcome
body -X- _ I-Outcome
weight -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
plateau -X- _ I-Outcome
pressures -X- _ I-Outcome
always -X- _ I-Outcome
remained -X- _ I-Outcome
< -X- _ I-Outcome
30 -X- _ I-Outcome
cmH -X- _ I-Outcome
( -X- _ I-Outcome
2 -X- _ I-Outcome
) -X- _ I-Outcome
O -X- _ I-Outcome
, -X- _ I-Outcome
without -X- _ I-Outcome
differences -X- _ I-Outcome
between -X- _ I-Outcome
survivors -X- _ I-Outcome
and -X- _ I-Outcome
non-survivors -X- _ I-Outcome
; -X- _ I-Outcome
and -X- _ I-Outcome
mean -X- _ I-Outcome
positive -X- _ I-Outcome
end- -X- _ I-Outcome
expiratory -X- _ I-Outcome
pressure -X- _ I-Outcome
( -X- _ I-Outcome
PEEP -X- _ I-Outcome
) -X- _ I-Outcome
levels -X- _ I-Outcome
used -X- _ I-Outcome
were -X- _ I-Outcome
between -X- _ I-Outcome
8 -X- _ I-Outcome
to -X- _ I-Outcome
12 -X- _ I-Outcome
cm -X- _ I-Outcome
H -X- _ I-Outcome
( -X- _ I-Outcome
2 -X- _ I-Outcome
) -X- _ I-Outcome
O. -X- _ I-Outcome
Rescue -X- _ I-Outcome
therapies -X- _ I-Outcome
, -X- _ I-Outcome
like -X- _ I-Outcome
recruitment -X- _ I-Outcome
maneuvers -X- _ I-Outcome
( -X- _ I-Outcome
8 -X- _ I-Outcome
to -X- _ I-Outcome
35 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
prone -X- _ I-Outcome
positioning -X- _ I-Outcome
( -X- _ I-Outcome
12 -X- _ I-Outcome
to -X- _ I-Outcome
24 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
and -X- _ I-Outcome
tracheal -X- _ I-Outcome
gas -X- _ I-Outcome
insufflation -X- _ I-Outcome
( -X- _ I-Outcome
3 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
were -X- _ I-Outcome
frequently -X- _ I-Outcome
applied. -X- _ I-Outcome
At -X- _ I-Outcome
all -X- _ I-Outcome
time -X- _ I-Outcome
points -X- _ I-Outcome
, -X- _ I-Outcome
pH -X- _ I-Outcome
, -X- _ I-Outcome
platelet -X- _ I-Outcome
count -X- _ I-Outcome
, -X- _ I-Outcome
lactate -X- _ I-Outcome
dehydrogenase -X- _ I-Outcome
assay -X- _ I-Outcome
( -X- _ I-Outcome
LDH -X- _ I-Outcome
) -X- _ I-Outcome
and -X- _ I-Outcome
Sequential -X- _ I-Outcome
Organ -X- _ I-Outcome
Failure -X- _ I-Outcome
Assessment -X- _ I-Outcome
( -X- _ I-Outcome
SOFA -X- _ I-Outcome
) -X- _ I-Outcome
differed -X- _ I-Outcome
significantly -X- _ I-Outcome
between -X- _ I-Outcome
survivors -X- _ I-Outcome
and -X- _ I-Outcome
non-survivors. -X- _ I-Outcome
Lack -X- _ I-Outcome
of -X- _ I-Outcome
recovery -X- _ I-Outcome
of -X- _ I-Outcome
platelet -X- _ I-Outcome
count -X- _ I-Outcome
and -X- _ I-Outcome
persistence -X- _ I-Outcome
of -X- _ I-Outcome
leukocytosis -X- _ I-Outcome
were -X- _ I-Outcome
characteristic -X- _ I-Outcome
of -X- _ I-Outcome
non-survivors. -X- _ I-Outcome
Mortality -X- _ I-Outcome
was -X- _ I-Outcome
high -X- _ I-Outcome
( -X- _ I-Outcome
46 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
; -X- _ I-Outcome
and -X- _ I-Outcome
length -X- _ I-Outcome
of -X- _ I-Outcome
MV -X- _ I-Outcome
was -X- _ I-Outcome
10 -X- _ I-Outcome
( -X- _ I-Outcome
6 -X- _ I-Outcome
to -X- _ I-Outcome
17 -X- _ I-Outcome
) -X- _ I-Outcome
days. -X- _ I-Outcome
CONCLUSIONS -X- _ O
: -X- _ O
These -X- _ O
patients -X- _ O
had -X- _ O
severe -X- _ O
, -X- _ O
hypoxemic -X- _ O
respiratory -X- _ O
failure -X- _ O
compatible -X- _ O
with -X- _ O
ARDS -X- _ O
that -X- _ O
persisted -X- _ O
over -X- _ O
time -X- _ O
, -X- _ O
frequently -X- _ O
requiring -X- _ O
rescue -X- _ O
therapies -X- _ O
to -X- _ O
support -X- _ O
oxygenation. -X- _ O
NIV -X- _ O
use -X- _ O
is -X- _ O
not -X- _ O
warranted -X- _ O
, -X- _ O
given -X- _ O
its -X- _ O
high -X- _ O
failure -X- _ O
rate. -X- _ O
Death -X- _ B-Outcome
and -X- _ I-Outcome
evolution -X- _ I-Outcome
to -X- _ I-Outcome
prolonged -X- _ I-Outcome
mechanical -X- _ I-Outcome
ventilation -X- _ I-Outcome
were -X- _ I-Outcome
common -X- _ I-Outcome
outcomes. -X- _ I-Outcome
Persistence -X- _ I-Outcome
of -X- _ I-Outcome
thrombocytopenia -X- _ I-Outcome
, -X- _ I-Outcome
acidosis -X- _ I-Outcome
and -X- _ I-Outcome
leukocytosis -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
high -X- _ I-Outcome
LDH -X- _ I-Outcome
levels -X- _ I-Outcome
found -X- _ I-Outcome
in -X- _ I-Outcome
non-survivors -X- _ I-Outcome
during -X- _ O
the -X- _ O
course -X- _ O
of -X- _ O
the -X- _ O
disease -X- _ O
might -X- _ O
be -X- _ O
novel -X- _ O
prognostic -X- _ O
findings -X- _ O
. -X- _ O

